Unveiling P. vivax invasion pathways in Duffy-negative individuals.

Duffy antigen receptor for chemokines Duffy-negativity Plasmodium vivax Sub-Saharan Africa erythropoiesis invasion pathways malaria

Journal

Cell host & microbe
ISSN: 1934-6069
Titre abrégé: Cell Host Microbe
Pays: United States
ID NLM: 101302316

Informations de publication

Date de publication:
13 Dec 2023
Historique:
received: 06 06 2023
revised: 01 10 2023
accepted: 08 11 2023
pubmed: 7 12 2023
medline: 7 12 2023
entrez: 6 12 2023
Statut: ppublish

Résumé

Vivax malaria has long been thought to be absent from sub-Saharan Africa owing to the high proportion of individuals lacking the Duffy antigen receptor for chemokines (DARC) in their erythrocytes. The interaction between P. vivax Duffy-binding protein (PvDBP) and DARC is assumed to be the main pathway used by merozoites to invade reticulocytes. However, the increasing number of reports of vivax malaria cases in genotypically Duffy-negative (DN) individuals has raised questions regarding the P. vivax invasion pathway(s). Here, we show that a subset of DN erythroblasts transiently express DARC during terminal erythroid differentiation and that P. vivax merozoites, irrespective of their origin, can invade DARC+ DN erythroblasts. These findings reveal that a large number of DN individuals may represent a silent reservoir of deep P. vivax infections at the sites of active erythropoiesis with low or no parasitemia, and it may represent an underestimated biological problem with potential clinical consequences in sub-Saharan Africa.

Identifiants

pubmed: 38056460
pii: S1931-3128(23)00457-2
doi: 10.1016/j.chom.2023.11.007
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

2080-2092.e5

Informations de copyright

Copyright © 2023 The Author(s). Published by Elsevier Inc. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of interests The authors declare no competing interests.

Auteurs

Isabelle Bouyssou (I)

Malaria Genetics and Resistance Unit, INSERM U1201, Institut Pasteur, Université Paris Cité, 75015 Paris, France; École Doctorale ED515 "Complexité du Vivant", Sorbonne Université, 75005 Paris, France; Malaria Parasite Biology and Vaccines Unit, Institut Pasteur, Université Paris Cité, 75015 Paris, France.

Sara El Hoss (S)

Red Cell Haematology Laboratory, Comprehensive Cancer Centre, School of Cancer and Pharmaceutical Sciences, King's College London, London SE5 9NU, UK. Electronic address: sara.el_hoss@kcl.ac.uk.

Cécile Doderer-Lang (C)

Institute of Parasitology and Tropical Diseases, UR7292 Dynamics of Host-Pathogen Interactions, Université de Strasbourg, 67000 Strasbourg, France.

Matthieu Schoenhals (M)

Immunology of Infectious Diseases, Institut Pasteur of Madagascar, Antananarivo 101, Madagasca.

Lova Tsikiniaina Rasoloharimanana (LT)

Immunology of Infectious Diseases, Institut Pasteur of Madagascar, Antananarivo 101, Madagasca.

Inès Vigan-Womas (I)

Institut Pasteur de Dakar, Dakar 220, Senegal.

Arsène Ratsimbasoa (A)

Faculté de Médecine, Université de Fianarantsoa, Fianarantsoa 301, Madagascar.

Andargie Abate (A)

Aklilu Lemma Institute of Pathobiology, Addis Ababa University, PO Box 1176, Addis Ababa, Ethiopia.

Lemu Golassa (L)

Aklilu Lemma Institute of Pathobiology, Addis Ababa University, PO Box 1176, Addis Ababa, Ethiopia.

Solenne Mabilotte (S)

Institute of Parasitology and Tropical Diseases, UR7292 Dynamics of Host-Pathogen Interactions, Université de Strasbourg, 67000 Strasbourg, France.

Pascal Kessler (P)

Centre de Recherche en Biomédecine de Strasbourg, Université de Strasbourg, 67000 Strasbourg, France.

Micheline Guillotte-Blisnick (M)

Malaria Parasite Biology and Vaccines Unit, Institut Pasteur, Université Paris Cité, 75015 Paris, France.

Francisco J Martinez (FJ)

Malaria Parasite Biology and Vaccines Unit, Institut Pasteur, Université Paris Cité, 75015 Paris, France.

Chetan E Chitnis (CE)

Malaria Parasite Biology and Vaccines Unit, Institut Pasteur, Université Paris Cité, 75015 Paris, France.

John Strouboulis (J)

Red Cell Haematology Laboratory, Comprehensive Cancer Centre, School of Cancer and Pharmaceutical Sciences, King's College London, London SE5 9NU, UK. Electronic address: john.strouboulis@kcl.ac.uk.

Didier Ménard (D)

Malaria Genetics and Resistance Unit, INSERM U1201, Institut Pasteur, Université Paris Cité, 75015 Paris, France; Malaria Parasite Biology and Vaccines Unit, Institut Pasteur, Université Paris Cité, 75015 Paris, France; Institute of Parasitology and Tropical Diseases, UR7292 Dynamics of Host-Pathogen Interactions, Université de Strasbourg, 67000 Strasbourg, France; Laboratory of Parasitology and Medical Mycology, CHU Strasbourg, 67000 Strasbourg, France. Electronic address: dmenard@pasteur.fr.

Classifications MeSH